Changing Healthcare Worldwide

Dedicated to building
better products

TDSC, through its academic collaboration with St. Bartholomew’s Hospital and the Royal London Hospital, has completed trials of 18 different molecules, including five human trials, two of which have been published in peer-reviewed publications. The pre-clinical work set out to establish that the TDSC's technology was able to deliver and accomplish blood levels with a diverse list of pharmaceutical actives.